Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Interview: Novartis Pharma President Kazunari Tsunaba Talks Market Adjustments, New Treatments and Technologies

Filed Under: Interviews Tagged With: , , , , , ,

Novartis Pharma KK appears to have turned the corner in terms of business performance. Sitting down for an interview with…...

Please subscribe to read the full story.
[lwa template="modal" register="0"] Register Free Trial

Related Articles:

Daiichi Sankyo Partners With US Firm to Enter Cancer Cell Therapy MarketDaiichi Sankyo Partners With US Firm to Enter Cancer…
Interview: Meiji Seika Pharma President Talks Drug Pricing Reform, Business TargetsInterview: Meiji Seika Pharma President Talks Drug…
Daiichi Sankyo Sees Pillar of Growth in Next-Gen BiopharmaceuticalsDaiichi Sankyo Sees Pillar of Growth in Next-Gen…
Gilead Sciences Works on New Platform for Business GrowthGilead Sciences Works on New Platform for Business Growth
Interview: Pfizer Japan President Akihisa Harada Talks Business, New Drug DevelopmentsInterview: Pfizer Japan President Akihisa Harada…
Industry Outlook 2017: Pharmaceuticals Part 2 – M&AsIndustry Outlook 2017: Pharmaceuticals Part 2 – M&As

Send this to a friend